ClinicalTrials.gg
Active, not recruitingNCT03497520Updated Apr 19, 2024

The Effect of Asymmetric Spinal Stabilization Exercise on Scoliosis

An interventional study of asymmetric spinal stabilization exercise in Scoliosis Idiopathic, sponsored by Seoul National University Hospital. Active, not recruiting at 1 site in Korea, Republic of. Open to participants aged 8 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-19.

Primary conditionMotor Activity(the registry's first term)UnverifiedIs this wrong?Motor Activity is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Not applicable
Ages
8 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the effect of asymmetric spinal stabilization exercise on scoliosis

Read the detailed description
  • Design: Prospective study
  • Setting: hospital rehabilitation department
  • Intervention: Participants are educated asymmetric spinal stabilization exercise along scoliosis curve patterns, including the location of apex and the direction of convexity. After performing asymmetric spinal stabilization exercise, participants are compared the main outcome measures.
  • Main outcome measures: Cobb angle, Apical vertebral rotation in Adam's test, surface EMG, Scoliosis Research Society-22(SRS-22) quastionnaire
02

Conditions studied

  • Scoliosis Idiopathic

Browse trials for

Keywords

  • surface EMG
  • cobb angle
  • exercise
  • Spinal Curvatures
03

In context

Motor Activity Unverified

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

This study's planned enrollment of 150 is above the median of 60 across 8,388 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Compared within Motor Activity, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
8 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • who have idiopathic scoliosis, showing at Cobb's angle over 10 degrees on X-ray

Exclusion criteria

Exclusion Criteria:

  • Patients who underwent spinal surgery
  • Patients with spinal scoliosis due to cerebral palsy, muscle paralysis, polio, congenital spinal abnormalities
  • Patients observed with Cobb's angle less than 10 degrees, over 40 degrees
  • Patients complaining of acute low back pain
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    scoliosis patients

    scoliosis patients who have cobb angle over 10 degree perform asymmetric spinal stabilization exercise

    Behavioral: asymmetric spinal stabilization exercise

Interventions

  • Behavioralasymmetric spinal stabilization exercise

    The patients were educated to strengthening weakness side of spinal muscle, as asymmetric spinal stabilization exercise(ASSE) * before teach ASSE, the investigators will evaluate Cobb angle, Apical vertebral rotation in Adam's test, surface EMG, Scoliosis Research Society-22(SRS-22) quastionnaire for evaluation of scoliosis severity * after perform ASSE, the investigators will evaluate Cobb angle, Apical vertebral rotation in Adam's test, surface EMG, Scoliosis Research Society-22(SRS-22) quastionnaire for evaluation of scoliosis severity

06

What researchers measure

Primary outcomes

  1. cobb angle

    measure lateral curve of vertebra on spine x-ray AP view

    Time frame: through study completion, an average of 6 months

  2. Apical vertebral rotation

    angle of trunk rotation in Adam's test

    Time frame: through study completion, an average of 1 year

  3. surface electromyography

    surface muscle contraction of bilateral spinal muscle on T7, T12, L3

    Time frame: through study completion, an average of 6 months

Secondary outcomes

  1. Scoliosis Research Society-22(SRS-22) quastionnaire

    five different factors (pain, self-image/appearance, function/activity, mental health, and satisfaction with management, 5 = best; 1 = worst)the minimum and maximum score range is from 5 to 25

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2018 (actual). Primary completion is estimated for Dec 2024, 81 months after the start.

Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 81 months is above that.

Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 29, 2018
First posted
Apr 13, 2018
StartActual
Mar 29, 2018
Primary completionEst.
Dec 2024
CompletionEst.
Dec 2024
Last update
Apr 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03497520
Responsible party
Ju Seok Ryu (associate professor, Seoul National University Hospital) — Principal investigator
First posted
Apr 13, 2018
Start date
Mar 29, 2018
Primary completion
Dec 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Apr 19, 2024

Study contacts

Jusuk Ryu, M.D. PhD
study director · Seoul National University Bundang Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion